ArticleBMC medicine2023

ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization.

Xiaolin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.